Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Floyd, John R
ROADS, NCT04365374: Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile- (Radiation One and Done Study)	Recruiting	3	180	US	Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Carrier Tile Brachytherapy Therapy (CTBT), Stereotactic Radiation Therapy	GT Medical Technologies, Inc.	Brain Metastases	12/25	12/27
ReSPECT-GBM, NCT01906385: Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)	Recruiting	1/2	55	US	Rhenium Liposome Treatment, Rhenium-186 NanoLiposome	Plus Therapeutics, National Cancer Institute (NCI)	Glioma	01/25	01/25
ReSPECT-LM, NCT05034497: Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases	Recruiting	1	18	US	186RNL, Rhenium-186 NanoLiposome	Plus Therapeutics	Leptomeningeal Metastasis	12/25	06/26
NCT04427384: Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)	Recruiting	N/A	600	US	GammaTile	GT Medical Technologies, Inc.	Brain Tumor, Recurrent, Brain Tumor, Brain Tumor, Primary, Brain Tumor - Metastatic, Brain Tumor, Adult: Glioblastoma, Brain Tumor, Adult Meningioma	10/28	12/28